Five Prime Thera (FPRX) Stock Price & Overview

NASDAQ:FPRX

Current stock price

38
+0.01 (+0.03%)
At close:
38
0 (0%)
After Hours:

The current stock price of FPRX is 38 null. Today FPRX is up by 0.03%. In the past month the price increased by 0.32%. In the past year, price increased by 1257.14%.

FPRX Key Statistics

52-Week Range2.64 - 38.9
Current FPRX stock price positioned within its 52-week range.
1-Month Range37.6 - 38.01
Current FPRX stock price positioned within its 1-month range.
Market Cap
1.77B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.29
Dividend Yield
N/A

FPRX Stock Performance

Today
+0.03%
1 Week
+0.29%
1 Month
+0.32%
3 Months
+167.23%
Longer-term
6 Months +537.58%
1 Year +1,257.14%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

FPRX Stock Chart

Five Prime Thera / FPRX Daily stock chart

FPRX Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to FPRX. When comparing the yearly performance of all stocks, FPRX is one of the better performing stocks in the market, outperforming 99.32% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
FPRX Full Technical Analysis Report

FPRX Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to FPRX. FPRX has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
FPRX Full Fundamental Analysis Report

FPRX Earnings

Next Earnings DateN/A
Last Earnings DateN/A
FPRX Earnings History

FPRX Forecast & Estimates


Analysts
Analysts75
Price TargetN/A
EPS Next Y6.99%
Revenue Next YearN/A
FPRX Forecast & Estimates

FPRX Financial Highlights

Over the last trailing twelve months FPRX reported a non-GAAP Earnings per Share(EPS) of -2.29. The EPS increased by 41.58% compared to the year before.


Income Statements
Revenue(TTM)13.18M
Net Income(TTM)-84.33M
Industry RankSector Rank
PM (TTM) -639.92%
ROA -25.43%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%42.7%
Sales Q2Q%-122.06%
EPS 1Y (TTM)41.58%
Revenue 1Y (TTM)-11.4%
FPRX financials

FPRX Ownership

Ownership
Inst OwnersN/A
Shares46.57M
Float22.49M
Ins Owners2.82%
Short Float %N/A
Short RatioN/A
FPRX Ownership

About FPRX

Company Profile

Five Prime Therapeutics, Inc. is a biotechnology company. The company focuses on the discovery and development of protein therapeutics that blocks cancer and inflammatory disease processes. It operates primarily in the United States and Canada. Five Prime Therapeutics, Inc. is based in San Francisco, California.

Company Info

Five Prime Thera

111 Oyster Point Boulevard

South San Francisco CA 94080

CEO: Thomas Civik

Phone: 415-365-5600

Five Prime Thera / FPRX FAQ

Can you describe the business of Five Prime Thera?

Five Prime Therapeutics, Inc. is a biotechnology company. The company focuses on the discovery and development of protein therapeutics that blocks cancer and inflammatory disease processes. It operates primarily in the United States and Canada. Five Prime Therapeutics, Inc. is based in San Francisco, California.


What is the stock price of Five Prime Thera today?

The current stock price of FPRX is 38 null. The price increased by 0.03% in the last trading session.


Does FPRX stock pay dividends?

FPRX does not pay a dividend.


What is the ChartMill rating of Five Prime Thera stock?

FPRX has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the market cap for Five Prime Thera?

Five Prime Thera (FPRX) has a market capitalization of 1.77B null. This makes FPRX a Small Cap stock.